Rating History for 4D Molecular Therapeutics (FDMT) by Barclays

More Stocks Rated by Barclays | Latest Ratings for FDMT
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/28/2026 Eliana Merle New Coverage Overweight
(N/A)		 33.00
(N/A)		 7.97
(8.48)		 6.4% Details